Biocure Technology Inc. (CURE.X) Cuts Acquisition Shares to 11.3M, Extends Deadline
Published . Updated .
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
Biocure Technology Inc. amended its agreement to acquire Glorious Success Limited, reducing share consideration from 12,459,091 to 11,325,464 shares and extending the transaction deadline from December 31, 2026 to January 31, 2027. Closing remains subject to approvals and other
Directly affected
- No company is named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Biocure Technology Inc. (CURE.X) Cuts Acquisition Shares to 11.3M, Extends Deadline TradingView
Source: TradingView
This story
Dates written in “Biocure Technology Inc. (CURE.X) Cuts Acquisition Shares to 11.3M, Extends Deadline”: d extending the transaction deadline from (31 December 2026); deadline from December 31, 2026 to (31 January 2027).
This story
12 out of 100
“Biocure Technology Inc. (CURE.X) Cuts Acquisition Shares to 11.3M, Extends Deadline” scores 12 out of 100. The score uses 1 sources.